Background: Epidural clonidine produces analgesia without motor impairment, and is associated with a local anestheticsparing effect during labor. The authors have recently demonstrated that epidural neostigmine initiates selective labor analgesia devoid of adverse effects. Both drugs possess common analgesic mechanisms mediated through spinal acetylcholine release. This study evaluates their epidural combination in parturients.
UNTIL now, local anesthetics have been used as a cornerstone to induce and maintain neuraxial analgesia during labor. Clinical trials conducted during the past years have sought to minimize the most noticeable side effects inherent to their administration, i.e., motor impairment and sympathetic block. However, even at low doses, local anesthetics still may interfere with the normal course of labor and increase the rate of instrumental delivery when compared with systemic opioids. 1, 2 Clonidine, an ␣ 2 -adrenoceptor agonist that can be used as a spinal analgesic whose administration does not induce motor impairment, produces analgesia through a nonopioid mechanism and is therefore devoid of adverse effects such as nausea, pruritus, or respiratory depression. Furthermore, use of clonidine allows a subsequent local anesthetic-sparing effect throughout the course of labor. 3, 4 In laboring parturients, however, epidural or spinal use remains subject to caution because of doserelated side effects in the mother, mainly sedation and hypotension, and risks of alterations in heart rate and bradycardia in the fetus. 5 A few years ago, neostigmine, a cholinesterase inhibitor, was evaluated as a spinal analgesic in various acute pain conditions, including in laboring parturients. 6, 7 Intrathecal administration induces major gastrointestinal adverse effects precluding any clinical use, 6, 7 whereas epidural injection of neostigmine causes postoperative pain relief without particular side effects 8 and recently has provided effective analgesia when coadministered with sufentanil during the first stage of labor. 9 Epidural neostigmine does not induce respiratory depression, motor impairment, or hypotension and hence matches the characteristics requested to induce selective analgesia. Clonidine and neostigmine possess common mechanisms of action mediated through spinal release of acetylcholine, and beneficial interactions have been reported after neuraxial concurrent administration: enhancement of analgesia without enhancement of side effects in human volunteers 10 and reduction of the sympatholytic effect of clonidine by spinal neostigmine in animals. 11, 12 The current study evaluates the epidural combination of clonidine and neostigmine for labor analgesia. For this purpose, the efficacy of concurrent epidural administration of clonidine and neostigmine in the first stage of labor as well as the effect of both drugs on subsequent local anesthetic consumption throughout the course of labor are examined by comparison with use of epidural neostigmine or clonidine alone. 100 healthy parturients with American Society of Anesthesiologists physical status of I or II with a gestational age greater than 36 weeks and who requested epidural analgesia during labor were enrolled in the study. Lumbar epidural puncture was performed with an 18-gauge Tuohy needle, and an epidural catheter was inserted 4 cm at the L3-L4 level in all parturients. Exclusion criteria included obstetric complications (multiple pregnancy, premature labor, or nonvertex presentation), contraindications to regional analgesia, and accidental dural puncture when the epidural was performed. All parturients were in established labor (cervical dilatation inferior to 5 cm), and all received an oxytocin infusion during the course of labor.
The current study was conducted in a similar way as we did previously when evaluating the efficacy of epidural neostigmine and sufentanil combination in labor. 9 Pain was assessed with a 100-mm visual analog scale (VAS; 0 -100). When the VAS score reached the level of 30 (out of 100), an epidural test dose of 3 ml lidocaine, 2%, with 1:200,000 epinephrine was administered, and the parturients were randomly allocated to one of five study groups to receive, in a total volume of 12 ml, 150 g epidural clonidine (n ϭ 20), 750 g neostigmine (n ϭ 20), or a combination of 75 g clonidine with 250 g neostigmine (n ϭ 20), 500 g neostigmine (n ϭ 20), or 750 g neostigmine (n ϭ 20). Neostigmine was provided from the commercial solution of neostigmine methylsulfate (Prostigmine ® , 0.5 mg/ml; Roche, Summerville, NJ), and clonidine was provided from the commercial solution clonidine hydrochloride (Catapressan ® , 150 g/ml; Boehringer, Ingelheim, Germany). Safety assessment has been reported for spinal use of both drugs. 12 The decision to administer a dose of 750 g neostigmine alone resulted from our previous study on epidural neostigmine to induce labor analgesia, which found that at least 6 -7 g/kg (i.e., 500 g) was needed when combined with sufentanil. 9 The choice of epidural clonidine at dose of 150 g resulted from a review of the literature regarding its use in laboring parturients and balancing analgesic and well-known side effects. The data were collected by an anesthesiologist, either a resident or an attending, who was blinded to the patient groups and to the epidural drugs. Maternal and fetal vital parameters were continuously monitored throughout the course of labor. Pain score (VAS) was recorded 3, 5, 10, 15, 20, and 30 min after the epidural injection, and sensory block (ether test) and motor block in the lower limb (modified Bromage scale: from 1 ϭ complete motor blockade to 6 ϭ no weakness at all) were assessed 15 and 30 min after injection. The duration of analgesia was considered the time elapsed to the patient's first request for further analgesia. From that second epidural injection until delivery, the maintenance of analgesia was provided by continuous infusion with 0.1% ropivacaine (8 -10 ml/h) and rescue doses of local anesthetic as needed. The duration of the labor from the time of the first epidural injection until delivery, the mode of delivery (operative, vaginal instrumental, or spontaneous), and cervical dilatation at the time of second epidural injection were recorded. The total consumption of ropivacaine throughout the course of labor was calculated.
Maternal adverse events (nausea and vomiting, pruritus, sedation, hypotension) and fetal side effects (bradycardia during labor and low Apgar score) were also closely monitored.
Statistical Analysis
Results are expressed as mean Ϯ SD, 95% confidence interval, or median (interquartile range), as indicated. Demographic data and continuous variables were compared among the groups by analysis of variance and repeated measures, followed, if appropriate, by multiple comparison with the Tukey Honest Significant Difference test (Statistica; StatSoft, Tulsa, OK). Comparison of ordinal categorical data among groups was achieved by application of the Kruskal-Wallis test followed by the Wilcoxon rank sum test for multiple comparisons. Incidence of adverse effects and installation of satisfactory analgesia were compared among the groups by chisquare analysis corrected for multiple tests. A P value less than 0.05 was considered significant.
The number of patients in the different groups was based on preliminary data regarding duration of analgesia resulting from a first epidural bolus of 750 g neostigmine or 150 g clonidine alone. A prospective sample size calculation (SigmaStat; SPSS Science Software, London, United Kingdom) indicated that 20 subjects were required in each group to have a 80% power to detect a 25% difference at an ␣ level of 0.05 for the duration of analgesic effect after combination of the two drugs.
Results
One hundred patients were enrolled in the study. Variables including age, weight, and parity were similar among the groups, as was cervical dilatation at the first injection and when a second epidural injection was required (table 1) . Maternal hemodynamic parameters did not differ among the groups and remained stable in all the groups until 30 min after injection. Among the parturients who received epidural 150 g clonidine, 33% experienced significant hypotension, mainly observed at 90 min after injection, which was easily treated by fluid loading and ephedrine administration (table 2) .
Only epidural combinations of 75 g clonidine with 500 and 750 g neostigmine provided efficient analgesia that significantly reduced the initial VAS score ( fig. 1 ). To better compare the effectiveness of the various epidural solutions, the percentages of parturients presenting satisfactory analgesia (which we defined as a VAS score Ͻ 30) were evaluated at different time points after injection ( fig. 2 ). The 75 g clonidine-750 g neostigmine group afforded the best effectiveness to relieve pain in parturients, with more than 80% of them presenting satisfactory analgesia after 15 min. Although the 75 g clonidine-500 g neostigmine group presented results not statistically different from the 75 g clonidine-750 g neostigmine group, the onset time was slower, and only 72% of the parturients matched our criteria of satisfactory analgesia (VAS score Ͻ 30). The durations of analgesia resulting from this first top-up dose were comparable between the 75 g clonidine-500 g neostigmine and 75 g clonidine-750 g neostigmine groups (table 3) , with the effect of 75 g clonidine-750 g neostigmine lasting significantly longer than the effect of 150 g clonidine alone and 75 g clonidine-250 g neostigmine. Epidural neostigmine alone, 750 g (10 g/ kg), was ineffective to initiate labor analgesia and, in contrast with other groups receiving epidural clonidine, did not display a sparing effect of ropivacaine throughout the course of labor (table 3) .
The level of sensory block assessed at 30 min after epidural injection was similar in all groups, as was the degree of motor blockade. No significant motor impairment was observed in any group (table 3) .
Total duration of labor, mode of delivery, and neonatal outcome were comparable among all the groups (table  2) . Epidural neostigmine up to a dose of 750 g did not induce particular side effects in the mother or in the fetus. By comparison, 150 g epidural clonidine pro-duced some degree of maternal sedation and, more importantly, caused significant maternal hypotension resulting in alterations of fetal heart rate (fetal bradycardia, n ϭ 3, 13.5%) but without adverse consequence. No hypotension or sedation was observed in any of the groups involving an epidural combination of clonidine and neostigmine.
Discussion
The current results show that 75 g epidural clonidine with 500 g neostigmine or, better, 750 g neostigmine, induced selective analgesia, i.e., devoid of motor impairment or sympathetic block, for an average duration of 108 min (confidence interval, 83-133 min) in 80% of the parturients.
Besides the fact that neither drug causes motor impairment, they possess specific properties that are of interest for labor analgesia. Spinal clonidine, which action mimics activation of descending inhibitory pathways, inhibits behavioral and neurophysiologic effects after noxious visceral stimuli in animal models of colorectal distension 13 and, more recently, uterine cervical distension. 14 Clinical application of the drug in the context of visceral pain has therefore led to its use for labor analgesia in association with local anesthetics. 15 Neostigmine inhibits the breakdown of endogenous acetylcholine and indirectly stimulates both muscarinic and nicotinic receptors into the spinal cord, inducing effective analgesia via Data are expressed as mean Ϯ SD or * median (interquartile range). Cervical dilatation was recorded (1) before administration of the first epidural injection and (2) when the parturient requested a second epidural dose. Groups: 150 g epidural clonidine (C150), 750 g neostigmine (N750), 75 g epidural clonidine combined with 250, 500, and 750 g neostigmine (C75N250, C75N500, and C75N750, respectively). Maternal hypotension was defined as a decrease greater than 20% from baseline systolic blood pressure, and fetal bradycardia was defined as a fetal heart rate value between 80 and 100 beats/min during 3-5 min. Groups: 150 g epidural clonidine (C150), 750 g neostigmine (N750), 75 g epidural clonidine combined with 250, 500, and 750 g neostigmine (C75N250, C75N500, and C75N750, respectively).
the epidural route without the major gastrointestinal side effects related to its intrathecal administration. 8, 9 Because some experimental data have suggested a sex difference in cholinergic analgesia in favor of females, 16 the drug seems particularly indicated in the field of obstetric analgesia.
We have recently investigated the use of epidural neostigmine in combination with neostigmine in partu-rients 9 and found that 500 g neostigmine (determined as the minimal effective dose) induces selective analgesia in 90% of patients for a duration of 119 min (confidence interval, 106 -135 min), an effect comparable to that of 750 g neostigmine with 75 g clonidine. The current results support our previous observations showing that, coadministered with ropivacaine, sufentanil, or clonidine, epidural neostigmine at a dose less than 500 g (i.e., 5-6 g/kg) is ineffective in laboring parturients, 9, 17 in contrast to the analgesic effects observed for lower doses in postoperative conditions such as after cesarean delivery 18 or orthopedic surgery. 8 Moreover, epidural neostigmine alone, even at a dose of 750 g (i.e., 8-9 g/kg), does not provide satisfactory pain relief in the first stage of labor, as previously observed by other authors with intrathecal neostigmine alone. 19 One reason might be the fact that, as a consequence of the hydrophilic nature of the compound, the dose reaching the spinal cord (i.e., around 75 g in this case) was not large enough to be effective. In fact, an intrathecal dose of at least 100 g was needed to provide some analgesia in volunteers. 10 Furthermore, in humans, painful labor does not seem to activate spinal cholinergic pathways. 20 Another reason might be that neostigmine was reported to be more effective to relieve pain of somatic origin than of visceral origin, and the first stage of labor mostly implies visceral pain. 21 Several studies have evaluated neuraxial clonidine as an analgesic during labor 15 and have established that the optimal epidural dose, a compromise between analgesia and acceptable side effects, lies between 60 and 75 g (a dose lower than 60 g is ineffective, 3 whereas a dose larger than 100 g induces sedation and hypotension 5 ). In most of these clinical trials, clonidine added to the first epidural bolus improves the effect of local anesthetic used. By example, 75 g clonidine combined with 12.5 mg bupivacaine prolongs analgesia to 127 min (SD, 11 min) 22 and combined with 8 mg ropivacaine lasts for 132 min (SD, 48 min). 5 To our knowledge, few reports have assessed the efficacy of clonidine without local anesthetic during the first stage of labor. Chiari et al. 23 reported the effects of intrathecal clonidine (50 -200 g) as a sole analgesic. Buggy and MacDowell 24 combined 120 g epidural clonidine with -opioid fentanyl, and Connelly et al. 25 administered 75 g epidural clonidine with sufentanil in the first stage of labor. Without an epidural test dose, the former authors observed effective analgesia lasting for 80 min (interquartile range, 60 -90 min) after a median onset time of 20 -35 min, but although no motor impairment appeared, maternal hypotension occurred in 57% of the patients in relation to the dose of clonidine they received. 24 Using a test dose and epidural dose of clonidine similar to what we used, the latter authors reported a duration of analgesia of 178 min (SD, 55 min) when clonidine was coadministered with 20 g sufentanil. 25 Fig. 1 . Evolution of pain scores before (T0) and from 3 min until 30 min (T3 to T30) after epidural injection in the different groups of parturients. Groups: 150 g epidural clonidine (C150), 750 g neostigmine (N750), 75 g epidural clonidine combined with 250, 500, and 750 g neostigmine (C75N250, C75N500, and C75N750, respectively). * P < 0.05 with visual analog scale score at T0, before epidural injection. There are several reasons to combine clonidine with neostigmine for neuraxial analgesia, besides those aforementioned, which concern their use in the context of labor pain. The first is an enhancement of efficacy through a common analgesic mechanism: The principal site of action for clonidine-mediated analgesia is located at spinal cord level, partly through spinal release of the endogenous neurotransmitter acetylcholine. 26 The second is a hemodynamic advantage resulting from opposite effects on the central sympathetic system: Spinal clonidine decreases sympathetic outflow in the spinal cord intermediolateral cell column, whereas neostigmine, through an enhanced acetylcholine release in preganglionic sympathetic neurons, increases sympathetic outflow. 11, 12 Experimental results in animals have demonstrated a synergistic effect in analgesia resulting from concurrent administration, 27 whereas in human volunteers, intrathecal neostigmine only enhances epidural analgesia from clonidine in an additive manner, but without enhancement of the side effects. 10 In parturients, both drugs have been coadministered as part of an intrathecal mixture to induce labor analgesia. Spinal clonidine, 50 g, prolonged analgesia provided by spinal sufentanil and bupivacaine; however, the addition of 10 g neostigmine to the mixture did not further potentiate the duration in a study by D'Angelo et al., 7 in contrast to a study by Owen et al., 6 who demonstrated that 10 g spinal neostigmine extended the duration of effect of spinal bupivacaine-fentanyl-clonidine 30 g from 123 to 165 min. In both studies, however, the dose of intrathecal neostigmine was hampered by severe nausea and vomiting.
Although it is difficult to compare our results to those aforementioned, which also involve an intrathecal local anesthetic and a -opioid agonist, we report here the first epidural combination of both drugs in early labor. Administration of 750 g epidural neostigmine (intrathecal equivalence of 75 g) 8 with 75 g epidural clonidine provides pain relief in early labor for 108 min (confi-dence interval, 83-133 min) without particular side effects. Specifically, we did not observe maternal hypotension among the women who received a combination of both drugs (i.e., 75 g clonidine with any of the three doses of neostigmine). Epidural clonidine at dose greater than 100 g is known to cause hypotension, 5 and lower doses, such as 60 or 75 g, have been shown to cause some hypotension, respectively 26% and 30%, when coadministered with ropivacaine. 3, 4 In the literature, 75 g spinal neostigmine injected at the same time as bupivacaine failed to prevent hypotension from local anesthetic in humans 28 but abolished clonidine-induced hypotension in a large animal model such as sheep. 11 One of the advantages of epidural clonidine lies in its local anesthetic dose-sparing effect throughout the course of labor: A single epidural dose of 60 -75 g at the beginning of labor provides 44 -64% of the ropivacaine dose-sparing effect. 3, 4 In the current study, we also demonstrated similar benefits with a reduction of 41% in ropivacaine requirements in all groups receiving epidural clonidine, regardless of the dose. In contrast, epidural neostigmine alone does not produce this effect. One potential explanation might be that epidural neostigmine alone, at the dose we used, was not effective in the parturients or to the underlying mechanisms of action of the drug. Neostigmine exerts an indirect analgesic effect in contrast with substances such as clonidine or -opioid agonists, which possess direct analgesic effect and have both demonstrated local anesthetic dose-sparing effects in labor. 3, 4, 29 In conclusion, epidural coadministration of 75 g clonidine with 500 g neostigmine or, better, 750 g neostigmine provides satisfactory and selective analgesia in early labor, without motor or sympathetic block or fetal side effects. Further, the use of epidural clonidine, devoid of bothersome consequence such as hypotension when combined with neostigmine, demonstrates a useful ropivacaine-sparing effect throughout the course of labor. Data are presented as mean Ϯ SD and * median value (interquartile range) or † (95% confidence interval) as indicated. ‡ P Ͻ 0.05 with C150 and C75N250; § P Ͻ 0.01 with N750; P Ͻ 0.01 with all the other groups. Visual analog scale (VAS) represents pain score (0 -100) evaluated by the parturients (1) before administration of the first epidural injection and (2) when the parturient requested a second epidural dose. The duration of epidural analgesia was calculated as the time elapsed between these two injections. Sensory level (ether test) and motor block (modified Bromage scale) were assessed at 30 min after injection. Groups: 150 g epidural clonidine (C150), 750 g neostigmine (N750), 75 g epidural clonidine combined with 250, 500, and 750 g neostigmine (C75N250, C75N500, and C75N750, respectively).
